Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | FOOD AND DRUG ADMINISTRATION has issued a Tender notice for the procurement of a Notice of Intent to Award a Sole Source Contract Sequencing Bundibugyo Virus Disease Bdbv in the 2026 Outbreak in the USA. This Tender notice was published on 27 Jul 2026 and is scheduled to close on 29 Jul 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 145987498, while the tender notice number is OC-2026-135667 and Registering on the platform.
Procurement Summary
Country: USA
Summary: Notice of Intent to Award a Sole Source Contract Sequencing Bundibugyo Virus Disease Bdbv in the 2026 Outbreak
Deadline: 29 Jul 2026
Posting Date: 27 Jul 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 145987498
Document Ref. No.: OC-2026-135667
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Procurement Type: Sole Source Simplified Acquisition Procedures (SAP) Purchase Order for Commercial Items
Authority: FAR Part 6.103-1, Only One Responsible Source
Subject: Notice of Intent to Award a Sole Source Contract - Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreak
Description: The Food and Drug Administration (FDA) intends to award a Sole Source firm-fixed price purchase order to The University of Liverpool for the Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreak, in accordance with the authority under FAR Part 6.103-1, Only One Responsible Source. This procurement is being conducted under simplified acquisition procedures in accordance with FAR Part 12 (RFO). The NAICS Code for this action is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).
The primary objective of this requirement is to obtain critical reagents such as procure reference standards and internal standards to perform bioanalytical method development and sample analysis to determine the quantification of CYP enzyme substrates/metabolites and transporter substrates in hepatocyte experiments.
Responses:
Responses to this notice should be sent to Ryan Alexander at [email protected] by 5:00 pm July 29, 2026. This notice is not a request for competitive quotes. Any other firms desiring consideration must fully identify their interest and capability of meeting the requirements by submitting a capability statement. Any response shall undergo review to determine if it can meet the requirements. A determination by the Government not to compete this proposed requirement based upon a response to this notice is solely within the discretion of the Government.
Notice ID: oc-2026-135667
Department/Ind. Agency: health and human services, department of
Sub-tier: food and drug administration
Product Service Code: an13 - health r&d services; health care services; experimental development
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Inactive Dates: aug 13, 2026
Inactive Policy: 15 days after response date
Documents
Procurement Documents for USA
Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google